
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
USF-1 CRISPR/Cas9 KO Plasmid (m) | sc-423628 | 20 µg | $397.00 |
Upstream transcription factor 1 (USF-1), encoded by the mouse Usf1 gene, is a basic helix–loop–helix leucine zipper transcription factor that binds E-box motifs to coordinate gene expression programs controlling metabolism, growth, and stress responses. USF-1 integrates signaling inputs to regulate transcriptional networks involved in lipid and glucose homeostasis, mitochondrial function, and cell-cycle progression, often through interactions with co-regulators and chromatin-modifying complexes. In murine systems, altered Usf1 activity has been associated with dysregulated metabolic phenotypes and inflammatory signaling that are relevant to studies of cardiometabolic traits and hepatic gene regulation. As a broadly expressed transcriptional regulator, USF-1 is frequently examined for its roles in transcriptional control, enhancer–promoter communication, and pathway crosstalk underlying complex disease susceptibility.
USF-1 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Usf1 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Usf1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Usf1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish USF-1 protein expression.
This CRISPR knockout system enables efficient generation of Usf1-deficient cell models for investigation of USF-1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.